Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Senate Bill Would Boost Oversight Of US FDA User Fee Program Following Trump Reorganization
Jul 14 2025
•
By
Sarah Karlin-Smith
Senate appropriators plan to keep a much closer eye on FDA user fee program spending in their FY 2026 spending bill.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from United States